Literature DB >> 29414102

Drp-1 dependent mitochondrial fragmentation and protective autophagy in dopaminergic SH-SY5Y cells overexpressing alpha-synuclein.

Jimena Hebe Martinez1, Agustina Alaimo2, Roxana Mayra Gorojod3, Soledad Porte Alcon4, Federico Fuentes5, Federico Coluccio Leskow6, Mónica Lidia Kotler7.   

Abstract

Parkinson's disease is a neurodegenerative movement disorder caused by the loss of dopaminergic neurons from substantia nigra. It is characterized by the accumulation of aggregated α-synuclein as the major component of the Lewy bodies. Additional common features of this disease are the mitochondrial dysfunction and the activation/inhibition of autophagy both events associated to the intracellular accumulation of α-synuclein. The mechanism by which these events contribute to neural degeneration remains unknown. In the present work we investigated the effect of α-synuclein on mitochondrial dynamics and autophagy/mitophagy in SH-SY5Y cells, an in vitro model of Parkinson disease. We demonstrated that overexpression of wild type α-synuclein causes moderated toxicity, ROS generation and mitochondrial dysfunction. In addition, α-synuclein induces the mitochondrial fragmentation on a Drp-1-dependent fashion. Overexpression of the fusion protein Opa-1 prevented both mitochondrial fragmentation and cytotoxicity. On the other hand, cells expressing α-synuclein showed activated autophagy and particularly mitophagy. Employing a genetic strategy we demonstrated that autophagy is triggered in order to protect cells from α-synuclein-induced cell death. Our results clarify the role of Opa-1 and Drp-1 in mitochondrial dynamics and cell survival, a controversial α-synuclein research issue. The findings presented point to the relevance of mitochondrial homeostasis and autophagy in the pathogenesis of PD. Better understanding of the molecular interaction between these processes could give rise to novel therapeutic methods for PD prevention and amelioration.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Parkinson's Disease; alpha-synuclein; autophagy; mitochondria; mitochondrial dynamics; mitophagy

Mesh:

Substances:

Year:  2018        PMID: 29414102     DOI: 10.1016/j.mcn.2018.01.004

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  19 in total

Review 1.  The unlikely partnership between LRRK2 and α-synuclein in Parkinson's disease.

Authors:  Noémie Cresto; Camille Gardier; Francesco Gubinelli; Marie-Claude Gaillard; Géraldine Liot; Andrew B West; Emmanuel Brouillet
Journal:  Eur J Neurosci       Date:  2018-10-24       Impact factor: 3.386

Review 2.  Mitophagy in Human Diseases.

Authors:  Laura Doblado; Claudia Lueck; Claudia Rey; Alejandro K Samhan-Arias; Ignacio Prieto; Alessandra Stacchiotti; Maria Monsalve
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

3.  Drp-1-Dependent Mitochondrial Fragmentation Contributes to Cobalt Chloride-Induced Toxicity in Caenorhabditis elegans.

Authors:  Fuli Zheng; Pan Chen; Huangyuan Li; Michael Aschner
Journal:  Toxicol Sci       Date:  2020-09-01       Impact factor: 4.849

Review 4.  Mitochondrial dynamics and its impact on human health and diseases: inside the DRP1 blackbox.

Authors:  Riddhi Banerjee; Agradeep Mukherjee; Shirisha Nagotu
Journal:  J Mol Med (Berl)       Date:  2021-10-16       Impact factor: 4.599

Review 5.  Autophagy in Parkinson's Disease.

Authors:  Xu Hou; Jens O Watzlawik; Fabienne C Fiesel; Wolfdieter Springer
Journal:  J Mol Biol       Date:  2020-02-13       Impact factor: 5.469

6.  Andrographolide alleviates Parkinsonism in MPTP-PD mice via targeting mitochondrial fission mediated by dynamin-related protein 1.

Authors:  Ji Geng; Wen Liu; Jian Gao; Chunhong Jiang; Ting Fan; Yang Sun; Zheng-Hong Qin; Qiang Xu; Wenjie Guo; Jing Gao
Journal:  Br J Pharmacol       Date:  2019-11-14       Impact factor: 8.739

7.  Gypenoside Inhibits Endothelial Cell Apoptosis in Atherosclerosis by Modulating Mitochondria through PI3K/Akt/Bad Pathway.

Authors:  Nan Song; Lianqun Jia; Huimin Cao; Yixin Ma; Ning Chen; Si Chen; Xiaoming Lv; Guanlin Yang
Journal:  Biomed Res Int       Date:  2020-06-20       Impact factor: 3.411

Review 8.  Recent Insights into the Interplay of Alpha-Synuclein and Sphingolipid Signaling in Parkinson's Disease.

Authors:  Joanna A Motyl; Joanna B Strosznajder; Agnieszka Wencel; Robert P Strosznajder
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

9.  The parkinsonian LRRK2 R1441G mutation shows macroautophagy-mitophagy dysregulation concomitant with endoplasmic reticulum stress.

Authors:  Sokhna M S Yakhine-Diop; Mario Rodríguez-Arribas; Saray Canales-Cortés; Guadalupe Martínez-Chacón; Elisabet Uribe-Carretero; Mercedes Blanco-Benítez; Gema Duque-González; Marta Paredes-Barquero; Eva Alegre-Cortés; Vicente Climent; Ana Aiastui; Adolfo López de Munain; José M Bravo-San Pedro; Mireia Niso-Santano; José M Fuentes; Rosa A González-Polo
Journal:  Cell Biol Toxicol       Date:  2021-05-31       Impact factor: 6.819

Review 10.  Mechanisms and roles of mitophagy in neurodegenerative diseases.

Authors:  Yan Wang; Na Liu; Bingwei Lu
Journal:  CNS Neurosci Ther       Date:  2019-05-02       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.